Lactomezole, a safe and effective eradication therapy for H. Pylori without the use of antibiotics


Project title
Lactomezole, a safe and effective eradication therapy for H. Pylori without the use of antibiotics
Code
AVVALACT
Project Coordinator
Start date
03-04-2017
Expected Completion
02-04-2020
 
Abstract
To develop a product, Lactomezole, as a new innovative standard of care for the management of dyspepsia and first line treatment for H. pylori infection, which is associated with dyspeptic and gastro-intestinal conditions, including gastric cancer. Lactomezole has significant OTC potential, as it will be the first proton pump inhibitor (PPI) plus prebiotic combo that has demonstrated eradication of H. pylori and normalization of GI tract microbiota without the use of antibiotics.